Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users

被引:2
|
作者
Pirodda, Antonio [1 ]
Raimondi, Maria Chiara [1 ]
Cicero, Arrigo Francesco Giuseppe [2 ]
Rosticci, Martina [2 ]
Rinaldi, Elisa Rebecca [2 ]
Bellacosa, Lara [2 ]
Stanghellini, Vincenzo [2 ]
Borghi, Claudio [2 ]
机构
[1] Univ Bologna, Dept Expt Diagnost & Specialty Med, Via Massarenti,9, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
关键词
proton pump inhibitors; inner ear disorders;
D O I
10.3109/21695717.2014.902554
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Objective: We wished to observe the prevalence of tinnitus in subjects on therapy with proton pump inhibitors (PPI). A possible favourable effect of the commercially available proton pump inhibitors (PPI) on inner ear disorders was recently outlined. In order to investigate this possibility the prevalence of tinnitus (an indicator of labyrinthine sufferance in general terms) among PPI users and non-users was analysed. Study design: An observational study on the prevalence of tinnitus among PPI users and non-users was carried out. Between June 2012 and March 2013 a cohort of consecutive patients who were referred to S. Orsola-Malpighi University Hospital of Bologna for various non-audiological disorders was included in the study. Each patient was instructed to complete an anonymous validated questionnaire on hearing problems. The Ethics Committee of S. Orsola Malpighi Hospital had been informed about collection of the data. Results: In the age class 60-69 years there was a statistically significant lower prevalence of non-specified tinnitus in PPI users, compared to non-users. Conclusion: Even if a favourable effect on this symptom derived from the treatment of gastroesophageal reflux cannot be excluded, a direct regulatory effect on inner ear homeostasis, through the action of PPI on the gastric type proton pump of the inner ear, cannot be ruled out. Another possible effect could depend upon vasomotor activity enabling better peripheral perfusion without significantly modifying blood pressure values, thus contributing to the stabilization of inner ear oxygenation. Additionally, a certain degree of anti-inflammatory effect could yield another kind of non-specific favourable influx. In conclusion, even if the supposed benefit deriving from the use of PPI in treating inner ear affections of unknown origin is still unclear with regard to its significance and limits, the reported results demonstrate that longitudinal studies could be useful in order to verify the possibility of a new therapeutic perspective.
引用
收藏
页码:84 / 87
页数:4
相关论文
共 50 条
  • [21] Proton pump inhibitors: perspectives of patients and their GPs
    Grime, J
    Pollock, K
    Blenkinsopp, A
    BRITISH JOURNAL OF GENERAL PRACTICE, 2001, 51 (470) : 703 - 711
  • [22] Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease
    Hoeer, Ariane
    Gothe, Holger
    Schiffhorst, Guido
    Sterzel, Astrid
    Grass, Ulrich
    Haeussler, Bertram
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (08) : 854 - 858
  • [23] Proton-Pump Inhibitors in Patients Requiring Antiplatelet Therapy: New FDA Labeling
    Johnson, David A.
    Chilton, Robert
    Liker, Harley R.
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 239 - 245
  • [24] Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
    Namikawa, Ken
    Bjornsson, Einar Stefan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [25] Risk of GERD-Related Disorders in Obese Patients on PPI Therapy: a Population Analysis
    Erridge, Simon
    Moussa, Osama M.
    Ziprin, Paul
    Darzi, Ara
    Purkayastha, Sanjay
    OBESITY SURGERY, 2018, 28 (09) : 2796 - 2803
  • [26] The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapy
    Li, Manyu
    Zeng, Chaofan
    Yao, Jiannan
    Ge, Yang
    An, Guangyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [27] Proton Pump Inhibitors in Pediatrics: Evaluation of Efficacy in GERD Therapy
    Romano, Claudio
    Chiaro, Andrea
    Comito, Donatella
    Loddo, Italia
    Ferrau, Valeria
    CURRENT CLINICAL PHARMACOLOGY, 2011, 6 (01): : 41 - 47
  • [28] Proton pump inhibitors and sensitization of cancer cells to radiation therapy
    Hebert, Kassidy A.
    Bonnen, Mark D.
    Ghebre, Yohannes T.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy
    Fernando, Himawan
    Dart, Anthony M.
    Peter, Karlheinz
    Shaw, James A.
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 933 - 944
  • [30] Gastric corpus polyps associated with proton pump inhibitors therapy
    Yakoob, Javed
    Abbas, Zaigham
    Jafri, Wasim
    Ahmad, Zubair
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2008, 18 (03): : 172 - 173